Showing 1 - 6 results of 6 for search 'Cheng-Ying Chu', query time: 0.02s Refine Results
  1. 1
    Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer

    Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer by Chih-Chieh Tu, Tsung-Han Hsieh, Cheng-Ying Chu, Yu-Chen Lin, Bo-Jyun Lin, Chun-Han Chen

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Anatomical variations in 3D imaging: A case report of a dorsal metacarpal artery anomaly

    Anatomical variations in 3D imaging: A case report of a dorsal metacarpal artery anomaly by Shin-Yun Chen, Wei-Ta Chen, Tsorng-Harn Fong, Jiun-Lin Horng, Cheng-Ying Chu, Haojan Yang, Tien-Chun Yang

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer

    FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder... by Yu-Chen Lin, Cheng-Ying Chu, Tsung-Han Hsieh, Bo-Jyun Lin, Jing-Ping Liou, Yun Yen, Chun-Han Chen

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients

    Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients by Tzu-Chun Cheng, Mien-Chie Hung, Lu-Hai Wang, Shih-Hsin Tu, Chih-Hsiung Wu, Yun Yen, Chi-Long Chen, Jacqueline Whang-Peng, Wen-Jui Lee, You-Cheng Liao, Yu-Ching Lee, Min-Hsiung Pan, Hui-Kuan Lin, Huey-En Tzeng, Peixuan Guo, Cheng-Ying Chu, Li-Ching Chen, Yuan-Soon Ho

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients

    Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients by Tzu-Chun Cheng, Mien-Chie Hung, Lu-Hai Wang, Shih-Hsin Tu, Chih-Hsiung Wu, Yun Yen, Chi-Long Chen, Jacqueline Whang-Peng, Wen-Jui Lee, You-Cheng Liao, Yu-Ching Lee, Min-Hsiung Pan, Hui-Kuan Lin, Huey-En Tzeng, Peixuan Guo, Cheng-Ying Chu, Li-Ching Chen, Yuan-Soon Ho

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment

    IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment by Gilbert Aaron Lee, Justin Bo-Kai Hsu, Yu-Wei Chang, Li-Chun Hsieh, Yi-Tien Li, Ying Chieh Wu, Cheng-Ying Chu, Yung-Hsiao Chiang, Wan-Yuo Guo, Chih-Chun Wu, Liang-Wei Chen, Hung-Wen Kao, Wan-Li Lin, Li‑Wen Tseng, Ting-Wei Weng, Duen-Pang Kuo, Sho-Jen Cheng, Yung-Chieh Chen, Shiu-Wen Huang, Hsing-Jien Kung, Cheng-Yu Chen

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: